Jersey Shore University Medical Center

Clinical trials.

 

Jersey Shore University Medical Center is one of several large hospitals making up the Meridian Health system. This facility is a teaching hospital that sees more than 25,000 admissions annually and performs more than 14,000 inpatient and outpatient surgeries every year. According to U.S. News & World Report, this hospital merits the magazine’s highest score for making use of advanced technology in its cancer care units. It earns top marks, too, for the comprehensiveness and quality of its cancer patient services. Those services include pain management and hospice. A part of the hospital is its Jersey Shore Cancer Center. This unit is accredited by the American College of Surgeons. It partners on cancer care clinical trials with the Rutgers Cancer Institute of New Jersey. The Commission on Cancer gave the center an award for outstanding achievement. Jersey Shore University Medical Center lists among its ambitions the delivery of quality, patient-centered health care services wherever needed — including the patient’s own home. This facility is noted for its participation in clinical trials. It operates a state-of-the-art clinical research center to accommodate those trials. The hospital participates in the systemwide Meridian Health Institute for Evidence-Based Care. This is an entity geared toward identifying and applying industry, market and clinical trends to improve patient safety and outcomes. Meridian indicates that this institute is the nation’s only evidence-based care center that takes an interdisciplinary approach to its mission.